Previous studies [12, 29] have demonstrated the anti-inflammatory activity of CLA, which blunts cytokine release in adipose tissues by inhibiting obesity-induced TNF-α and IL-6 [30, 43]. The gene discussed is TNF; the disease is obesity due to melanocortin 4 receptor deficiency.